Clinical Trial Update: Trametinib in the Treatment of Complicated Extracranial Arterial Venous Malformation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating trametinib for complicated extracranial arterial-venous malformation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arteriovenous Malformation
• Venous Malformation

Drugs mentioned

• Trametinib (Mekinist) (trametinib)

Snippet

Sponsor: Stanford University | Conditions: Venous Malformation, Arterial Disease | Phase 2 | Status: COMPLETED